Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 23.70
-0.10 (-0.42%)
Nov 10, 2026, 1:30 PM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.59 billion as of November 9, 2026. It is the 26,743rd most valuable company in the world and the 1,465th biggest in Taiwan. Its market cap has increased by 48.33% in one year.
Market Cap
2.59B
Enterprise Value
2.12B
Revenue
957.93M
Global Rank
Country Rank
#1,465 Taiwan
PE Ratio
15.35
ChartMarket Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.59B, an increase of 102.83%. That is a compound annual growth rate of 4.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 2.59B | 16.28% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Yoda Pharmaceuticals | 4.84B |
| LIWANLI Innovation | 4.35B |
| Panion & Bf Biotech | 4.20B |
| Orient EuroPharma | 3.67B |
| Easywell Biomedicals | 3.09B |
| Maywufa Company | 2.75B |
| TSH Biopharm Corporation | 2.25B |
| Merdury Biopharmaceutical | 2.22B |